Michael Dixon
Vorstandsvorsitzender bei Therillia Development Co., Inc.
Profil
Michael Dixon is currently the President, Chief Executive Officer & Director at Therillia Development Co., Inc. He is also the President, Chief Financial Officer & Director at Diazon Pharmaceuticals, Inc., a Director at Liphorus Pharmaceuticals, Inc., and the Managing Partner at Sanderling Management CO LLC.
Previously, he served as the Chief Financial Officer at Gemin X Pharmaceuticals US, Inc. and as a Consultant at PricewaterhouseCoopers China Ltd.
He also held the position of Chief Financial Officer at Sullivan Entertainment Group, Inc. from 1991 to 1992.
Mr. Dixon obtained his undergraduate degree from the University of Toronto in 1983.
Aktive Positionen von Michael Dixon
| Unternehmen | Position | Beginn |
|---|---|---|
Therillia Development Co., Inc.
 Therillia Development Co., Inc. Pharmaceuticals: MajorHealth Technology Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada. | Vorstandsvorsitzender | 04.03.2013 |
Liphorus Pharmaceuticals, Inc.
 Liphorus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Liphorus Pharmaceuticals, Inc. develops small molecules effective in treating high cholesterol. The company was founded in 2014 and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | - |
Diazon Pharmaceuticals, Inc.
 Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Präsident | - |
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | Private Equity Investor | 01.01.2013 |
Ehemalige bekannte Positionen von Michael Dixon
| Unternehmen | Position | Ende |
|---|---|---|
Sullivan Entertainment Group, Inc.
 Sullivan Entertainment Group, Inc. Movies/EntertainmentConsumer Services Sullivan Entertainment Group, Inc. engages in motion picture services. The private company is based in Toronto, Canada. | Finanzdirektor/CFO | 02.01.1992 |
PricewaterhouseCoopers China Ltd.
 PricewaterhouseCoopers China Ltd. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers China Ltd. is an audit firm. | Corporate Officer/Principal | - |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Finanzdirektor/CFO | - |
Ausbildung von Michael Dixon
| University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | Finance |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
PricewaterhouseCoopers China Ltd.
PricewaterhouseCoopers China Ltd. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers China Ltd. is an audit firm. | Commercial Services |
Sullivan Entertainment Group, Inc.
Sullivan Entertainment Group, Inc. Movies/EntertainmentConsumer Services Sullivan Entertainment Group, Inc. engages in motion picture services. The private company is based in Toronto, Canada. | Consumer Services |
Therillia Development Co., Inc.
Therillia Development Co., Inc. Pharmaceuticals: MajorHealth Technology Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada. | Health Technology |
Diazon Pharmaceuticals, Inc.
Diazon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada. | Health Technology |
Liphorus Pharmaceuticals, Inc.
Liphorus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Liphorus Pharmaceuticals, Inc. develops small molecules effective in treating high cholesterol. The company was founded in 2014 and is headquartered in Montréal, Canada. | Health Technology |
